Digital solutions save lives
Digital solutions save lives
Search
Social Impact | COVID-19 | Boehringer Ingelheim US
Click to find out more on how Boehringer Ingelheim (BI) is standing together with our communities to support the fight against the COVID-19 pandemic.
FDA Mini-Sentinel Assessment Reinforces Safety Data of Pradaxa® (dabigatran etexilate mesylate)
FDA Mini-Sentinel Assessment Reinforces Safety Data of Pradaxa® (dabigatran etexilate mesylate)
Boehringer Ingelheim Acquires AMAL Therapeutics
Boehringer Ingelheim Acquires AMAL Therapeutics
Advocating for More Patient-Centered Mental Health Care
Advocating for More Patient-Centered Mental Health Care
Clinical Pharmacology
Boehringer Ingelheim is proud to offer a new two-year fellowship within Clinical Pharmacology. Click here to find out more.
2024 BI Puerto Rico Holiday
directions_to_vab.pdf
pto_policy.pdf
Equitable access to Prescription Digital Therapeutics
Jentadueto-LongForm.pdf
West_Africa_TOCTA_2013_EN
Jentadueto XR® Overview Factsheet | PDF
Access to Healthcare Strategy PDF
Stiolto® Overview Factsheet | PDF
Stiolto® Respimat® Medication Guide
Stiolto 1
Stiolto 2
Total Rewards At a Glance.pdf
Victor Emenike
Victor Emenike is a data scientist in operations, specifically in the launch and innovation organization, feels valued and supported in new ideas.
Shannon Rountos
Shannon Rountos, Head of Newsroom within Corporate Affairs, speaks about her rewarding and fulfilling career in Boehringer Ingelheim.
Kei Kato
Kei Kato, Head of Purchasing in Japan, describes a career at Boehringer Ingelheim as intense and exciting.
FDA Approves Praxbind® (idarucizumab), Specific Reversal Agent for Pradaxa® (dabigatran etexilate mesylate)
FDA Approves Praxbind® (idarucizumab), Specific Reversal Agent for Pradaxa® (dabigatran etexilate mesylate)
BI Cares Financial Contributions Program
BI Cares Financial Contributions Program
New Long-Term Data Published in Circulation Reinforce Safety Profile of Pradaxa® (dabigatran etexilate mesylate)
New Long-Term Data Published in Circulation Reinforce Safety Profile of Pradaxa® (dabigatran etexilate mesylate)